The Bothell site is closing and 24 jobs are eliminated. All the biology work being transferred to Singapore. I love the phrase "further optimize its location footprint" to describe the closing of yet another US site. This will save the company about $2 million per year. Wow...the CEO took more than that out of the company in the first 9 months of this year as his Technology Incentive Award ($2.47 million). Again I ask, why do the shareholders of this publicly traded company allow the CEO to personally and solely take 10% of the revenues from the only profitable part of the business? While at the same time continuing to eliminate US jobs and shift them overseas? I really don't get it. I'd rather live on the streets than work at that company. And no I'm not a former disgruntled employee, just someone who has watched, amazed for over a decade, that the CEO of a public company is allowed to skim so much cash from a company losing money.
Another loss for AMRI, the most boring company in the world. Nothing ever happens at AMRI except operating at a loss, and the CEO skimming 10% of the royalty stream year after year after year. No wonder a measly 45,000 shares change hands on a daily average. There is no long-term upside potential for AMRI, why would anyone put their money in this yawn of a company?
"How many times will AMRI have to "streamline" before investors actually see evidence of improving margins? Over the years AMRI has issued a slew of comments and releases saying that management was turning around the company."
One quick way to immediately improve the margins...stop allowing the CEO to put 10% of the only profitable aspect of the business, the Allegra royalty, directly into his own pocket in the form of that shameful "technology incentive award". Why shareholders have put up with that is a complete mystery to me. This is up to over $50 million now. That's $50 million into the CEO's pocket, on top of his rich salary and stock holdings.
Name one other public company in which such a substantial percentage of a revenue stream goes to individual employees. Just one.
Bump. This question is even more timely now that staff is being sacked and the company is running out of cash. How can Tom justify STILL taking cash out of the company when it's losing money? Why have shareholders put up with this so long?
$46,713,000 straight into the CEO's pocket from 1996-2010, a full 10% of the Allegra royalty stream. Why didn't shareholders demand an end to this pillaging of the only profitable part of the company's business?
"Donkey, you are very aptly named. It's called . . . investing. Put it away and forget about it. This is the Microsoft of the 21st century. stop analysing. make an investment."
I am aptly named, but not for the reasons you think. Anyway, investing requires analysis, otherwise buying stock is simply gambling. This stock is way overbought. I could have held on and made another $50/share, but that's very easy to know after the fact. This stock has gotten too expensive too fast. It's bound to pull back, which is why I'm buying the hell out of $300 November puts.
"Boy, you longs have guts. Too rich for my blood, though. I cannot help thinking that someday soon there will be some hell to pay."
I'll say. I bought into ISRG in mid-September, at $216, and sold the day after the earnings release at $276, right before it slumped down into the $260's, and thought I was pretty amazing for catching the peak, with nearly a 30% gain for a 3-week hold. Then it took off again. I must say, I've been tempted to buy in again given the way it keeps rocketing up 2-4% per day, but this can't go on much longer. I don't see how this P/E can be supported. This has gotten way too expensive for me.